Neurobiological mechanisms of motor and motivation deficits of dopamine

• Autorzy: Stasny P. , Petr M. , Rzeszutko-Polak A. , Niewczas M. , Krol P. , Czarny W. , Niewczas-Czarny P. , Chmielowiec J. , Masiak J. , Trybek G. , Moska W. , Gronek J. , Cieszczyk P.
• Języki publikacji: EN

Abstrakty

EN

Dopamine (3,4-dihydroxyphenethylamine) together with adrenaline and noradrenaline belong to the group of catecholamines present in different tissues, predominantly in the nervous system, where they function as neurotransmitters. Our choice of the genetic determinants of the dopaminergic system disorders for the main topic of our project study was influenced by a wide spectrum of influence which the system has on the functions of an organism connected with, for example, its adaptive response to physical effort (it is the very adrenergic system that physiologists call the “work and fight” and even the “fight and flight” system). It is, for example, proven by the confirmed influence of dopaminergic mechanisms on blood pressure, widening of bronchi and a mobilization of energetic substrates. On the other hand, it is worth mentioning another importance of dopamine recognized by psychologists and psychiatrists as the hormone of “motivation, thrill and adventure seeking”, which in sport can be of key importance. That is why we would like to link these two areas – genetic and psychological.

• Wydawca: -
• Czasopismo: Trends in Sport Sciences
• Rocznik: 2017
• Tom: 24
• Numer: 3
• Opis fizyczny: p.105-110,ref.

Twórcy

autor

Stasny P.

• Department of Sport Games, Charles University in Prague, Prague, Czech Republic

autor

Petr M.

• Department of Sport Games, Charles University in Prague, Prague, Czech Republic

autor

Rzeszutko-Polak A.

• Faculty of Physical Education, University of Rzeszow, Rzeszow, Poland

autor

Niewczas M.

• Faculty of Physical Education, University of Rzeszow, Rzeszow, Poland

autor

Krol P.

• Faculty of Physical Education, University of Rzeszow, Rzeszow, Poland

autor

Czarny W.

• Faculty of Physical Education, University of Rzeszow, Rzeszow, Poland

autor

Niewczas-Czarny P.

• Faculty of Physical Education, University of Rzeszow, Rzeszow, Poland

autor

Chmielowiec J.

• Department of Public Health, Faculty of Medicine and Health Sciences, University of Zielona Gora, Zielona Gora, Poland

autor

Masiak J.

• Independent Laboratory of Neurophysiology Research, Department of Psychiatry, Medical University of Lublin, Lublin, Poland

autor

Trybek G.

• Department of Oral Surgery, Pomeranian Medical University, Szczecin, Poland

autor

Moska W.

• Department of Tourism and Recreation, University of Physical Education and Sport, Gdansk, Poland

autor

Gronek J.

• Laboratory of Genetics, Department of Gymnastics and Dance, Poznan University of Physical Education, Poznan, Poland

autor

Cieszczyk P.

• Department of Physical Education, University of Physical Education and Sport, Gdansk, Poland

Bibliografia

• 1. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009; 10: 189-198.
• 2. Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012; 15(3): 405-411.
• 3. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet. 1996; 12(1): 81-84.
• 4. Blanco NJ, Love BC, Cooper JA, McGeary JE, Knopik VS, Maddox WT. A frontal dopamine system for reflective exploratory behavior. Neurobiol Learn Mem. 2015; 22: 1074-1077.
• 5. Brown CA, Campbell MC, Karimi M, Tabbal SD, Loftin SK, Tian LL, et al. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys. Exp Neurol. 2012; 236: 190-197.
• 6. Brown RG, Pluck G. Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour. Trends Neurosci. 2000; 23: 412-417.
• 7. Caceda R, Nemeroff CB, Harvey PD. Toward an understanding of decision making in severe mental illness. J Neuropsychiatry Clin Neurosci. 2014; 26: 196-213.
• 8. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson’s disease: influence of dopatherapy. Neuropsychologia, 2002; 40: 2257-2267.
• 9. De Haan JB, Gevers W, Parker MI. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res. 1986; 46: 713-716.
• 10. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol. 1998; 12(1): 54-67.
• 11. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol. 1999; 375(1-3): 13-30.
• 12. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988; 85(14): 5274-5278.
• 13. Di Chiara G, Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther. 1988; 244(3): 1067-1080.
• 14. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet. 1996; 12(1): 78-80.
• 15. Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klinische Wochenschrift, 1960; 38: 1236-1239.
• 16. Gepshtein S, Li X, Snider J, Plank M, Lee D, Poizner H. Dopamine function and the efficiency of human movement. J Cogn Neurosci. 2014; 26(3): 645-657.
• 17. Ghods-Sharifi S. St Onge JR, Floresco SB. Fundamental contribution by the basolateral amygdala to different forms of decision making. J Neurosci. 2009; 29: 5251-5259.
• 18. Goschke T. Dysfunctions of decision-making and cognitive control as transdiagnostic mechanisms of mental disorders: advances, gaps, and needs in current research. Int J Methods Psychiatr Res. 2014; 23(Suppl 1): 41-57.
• 19. Hosking JG, Floresco SB, Winstanley CA. Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks. Neuropsychopharmacology, 2015; 40: 1005-1015.
• 20. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications. N Engl J Med. 1988; 318: 876-880.
• 21. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006; 31: 89-97.
• 22. Koob GF. Hedonic valence, dopamine and motivation. Mol Psychiatry. 1996; 1(3): 186-189.
• 23. Laucht M, Becker K, El-Faddagh M, Hohm E, Schmidt MH. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking? J Am Acad Child Adolesc Psychiatry. 2005; 44(5): 477-484.
• 24. Le Bouc R, Rigoux L, Schmidt L, Degos B, Welter ML, Vidailhet M, et al. Computational dissection of dopamine motor and motivational functions in humans. J Neurosci. 2016; 36(25): 6623-6633.
• 25. Noble EP, Ozkaragoz TZ, Ritchie TL, Zhang X, Belin TR, Sparkes RS. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet. 1998; 81(3): 257-267.
• 26. Nowak J, Zawilska J. Receptory i mechanizmy przekazywania sygnału. PWN, Warszawa; 2004.
• 27. Parker MI, de Haan JB and Gevers W. DNA hypermethylation in sodium butyrate-treated WI-38 fibroblasts. J Biol Chem. 1986; 261: 2786-2790.
• 28. Pasquereau B, Turner RS. Limited encoding of effort by dopamine neurons in a costbenefit trade-off task. Neurosci. 2013; 33(19): 8288-8300.
• 29. Redgrave P, Prescott T, Gurney K. Is the short-latency dopamine response too short to signal reward error? Trends in Neurosciences, 1999; 22: 146-151.
• 30. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 2005; 128: 1314-1322.
• 31. Rigoux L, Guigon E. A model of reward – and effortbased optimal decision making and motor control. PLoS Comput Biol. 2012; 8: e1002716.
• 32. Salamone JD, Cousins MS, Bucher S. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure. Behav Brain Res. 1994; 65: 221-229.
• 33. Sander T, Harms H, Dufeu P, Kuhn S, Rommelspacher H, Schmidt LG. Dopamine D4 receptor exon III alleles and variation of novelty seeking in alcoholics. Am J Med Genet. 1997; 74(5): 483-487.
• 34. Schultz W. Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol. 1997; 7(2): 191-197.
• 35. Shadmehr R, Orban de Xivry JJ, Xu-Wilson M, Shih TY. Temporal discounting of reward and the cost of time in motor control. J Neurosci. 2010; 30: 10507-10516.
• 36. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci. 1992; 4: 134-139.
• 37. Stoddart JH, Lane MA, Niles RM. Sodium butyrate suppresses the transforming activity of an activated N-ras oncogene in human colon carcinoma cells. Exp Cell Res. 1989; 184: 16-27.
• 38. Suchanecka A. Rola dopaminy w procesach motywacyjnych i powstawaniu uzależnień. Ann Acad Med Stetin. 2013; 59, numer Sympozja 2: 158-161.
• 39. Thobois S, Ardouin C, Lhomme´e E, Klinger H, Lagrange C, Xie J i wsp. Non-motor dopamine withdrawal syndrome after surgery for Parkinson’s disease: predictors and underlying mesolimbic denervation. Brain, 2010; 133: 1111-1127.
• 40. Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, et al. Dopaminergic mechanisms of individual differences in human effort-based decisionmaking. J Neurosci. 2012; 32(18): 6170-6176.
• 41. Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the ‘EEfRT’? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One, 2009; 4: e6598.
• 42. Van Tol HH, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 1991; 350(6319): 610- 614.
• 43. Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H. Amping up effort: effects of d-amphetamine on human effortbased decision-making. J Neurosci. 2011; 31: 16597-16602.
• 44. Young AM, Ahier RG, Upton RL, Joseph MH, Gray JA. Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli. Neuroscience, 1998; 83(4): 1175-1183.

Identyfikatory

DOI

10.23829/TSS.2017.24.3-2